These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Potassium channels as pharmacological targets in cardiovascular medicine. Escande D; Henry P Eur Heart J; 1993 Jul; 14 Suppl B():2-9. PubMed ID: 8370367 [TBL] [Abstract][Full Text] [Related]
6. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries. Nielsen-Kudsk JE Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816 [TBL] [Abstract][Full Text] [Related]
7. Targeting of Potassium Channels in Cardiac Arrhythmias. Burg S; Attali B Trends Pharmacol Sci; 2021 Jun; 42(6):491-506. PubMed ID: 33858691 [TBL] [Abstract][Full Text] [Related]
8. Mild alkalinization and acidification differentially modify the effects of lidocaine or mexiletine on vasorelaxation mediated by ATP-sensitive K+ channels. Kinoshita H; Iranami H; Kimoto Y; Dojo M; Hatano Y Anesthesiology; 2001 Jul; 95(1):200-6. PubMed ID: 11465559 [TBL] [Abstract][Full Text] [Related]
9. Blockers of the ATP-sensitive potassium channel SUR2A/Kir6.2: a new approach to prevent sudden cardiac death. Englert HC; Heitsch H; Gerlach U; Knieps S Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):253-71. PubMed ID: 15326916 [TBL] [Abstract][Full Text] [Related]
10. Class IV antiarrhythmic agents: new compounds using an old strategy. Szentandrássy N; Nagy D; Hegyi B; Magyar J; Bányász T; P Nánási P Curr Pharm Des; 2015; 21(8):977-1010. PubMed ID: 25354181 [TBL] [Abstract][Full Text] [Related]
11. Evidence for the possible involvement of Ca2+ entry blockade in the relaxation by class I antiarrhythmic drugs in the isolated pig coronary smooth muscle. Tanaka Y; Kamibayashi M; Yamashita Y; Imai T; Tanaka H; Nakahara T; Ishii K; Shigenobu K Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):56-66. PubMed ID: 11862334 [TBL] [Abstract][Full Text] [Related]
12. The antiarrhythmic actions of bisaramil and penticainide result from mixed cardiac ion channel blockade. Pugsley MK; Hayes ES; Saint DA; Walker MJA Biomed Pharmacother; 2019 Mar; 111():427-435. PubMed ID: 30594781 [TBL] [Abstract][Full Text] [Related]
13. Potassium channel openers and other regulators of KATP channels. Challinor-Rogers JL; McPherson GA Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):583-97. PubMed ID: 7813118 [TBL] [Abstract][Full Text] [Related]
14. [Potassium channels and arrhythmia]. Funck-Brentano C Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():9-13. PubMed ID: 1307198 [TBL] [Abstract][Full Text] [Related]
15. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? Tosaki A; Szerdahelyi P; Engelman RM; Das DK J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798 [TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic effects of potassium channel openers. Haverkamp W; Borggrefe M; Breithardt G Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():195-202. PubMed ID: 7647023 [TBL] [Abstract][Full Text] [Related]
17. Potassium channels and human corporeal smooth muscle cell tone: diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers. Venkateswarlu K; Giraldi A; Zhao W; Wang HZ; Melman A; Spektor M; Christ GJ J Urol; 2002 Jul; 168(1):355-61. PubMed ID: 12050569 [TBL] [Abstract][Full Text] [Related]
18. Role of K+ channels in augmented relaxations to sodium nitroprusside induced by mexiletine in rat aortas. Kinoshita H; Ishikawa T; Hatano Y Anesthesiology; 2000 Mar; 92(3):813-20. PubMed ID: 10719960 [TBL] [Abstract][Full Text] [Related]
19. Current trends in the study of potassium channel openers. McPherson GA Gen Pharmacol; 1993 Mar; 24(2):275-81. PubMed ID: 8482511 [TBL] [Abstract][Full Text] [Related]